Evidence map›Paper›PMID 25651530›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Clotting activity of polyphosphate-functionalized silica nanoparticles.

Damien Kudela, Stephanie A Smith, Anna May-Masnou, Gary B Braun, Alessia Pallaoro, Chi K Nguyen, Tracy T Chuong, Sara Nownes, Riley Allen, Nicholas R Parker and 3 more

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Advanced applications of nanotechnology in veterinary medicine.Environmental science and pollution research international · 2020
    Review
  8. Silica nanomaterials induce organ injuries by CaParticle and fibre toxicology · 2020
    Article
  9. Application of some nanoparticles in the field of veterinary medicine.International journal of veterinary science and medicine · 2019
    Review
  10. Polyphosphate in thrombosis, hemostasis, and inflammation.Research and practice in thrombosis and haemostasis · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Bio-inspired nanomedicine strategies for artificial blood components.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  15. Article
  16. Article
  17. Polyphosphate, platelets, and coagulation.International journal of laboratory hematology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Damien KudelaDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA 93106 (USA). dkudela@chem.ucsb.edu.
Stephanie A Smith
Anna May-Masnou
Gary B Braun
Alessia Pallaoro
Chi K Nguyen
Tracy T Chuong
Sara Nownes
Riley Allen
Nicholas R Parker
Hooman H Rashidi
James H Morrissey
Galen D Stucky
University of California, Santa Barbara · USUniversity of Illinois Urbana-Champaign · USSanford Burnham Prebys Medical Discovery Institute · USUniversitat de Barcelona · ESUniversity of California, Davis · US

Funding

MECHANISMS OF TISSUE FACTOR/FACTOR VII ASSEMBLYR01HL047014 · NHLBI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI MORRISSEY, JAMES H. · 1992 to 2016
$4.9M
NHLBI NIH HHS R01 HL047014
6 · The paper itself

Abstract

We present a silica nanoparticle (SNP) functionalized with polyphosphate (polyP) that accelerates the natural clotting process of the body. SNPs initiate the contact pathway of the blood-clotting system; short-chain polyP accelerates the common pathway by the rapid formation of thrombin, which enhances the overall blood-clotting system, both by accelerating fibrin generation and by facilitating the regulatory anticoagulation mechanisms essential for hemostasis. Analysis of the clotting properties of bare SNPs, bare polyP, and polyP-functionalized SNPs in plasma demonstrated that the attachment of polyP to SNPs to form polyP-SNPs creates a substantially enhanced synergistic effect that lowers clotting time and increases thrombin production at low concentrations. PolyP-SNP even retains its clotting function at ambient temperature. The polyP-SNP system has the potential to significantly improve trauma-treatment protocols and outcomes in hospital and prehospital settings.

Indexed as

NanoparticlesBlood CoagulationFibrinHemorrhageHemostasisMagnetic Resonance SpectroscopyParticle SizePolyphosphatesSilicon DioxideSpectrophotometry, AtomicTemperatureThrombinWhole Blood Coagulation TimeZirconiumFibrinPolyphosphatesSilicon DioxideThrombinZirconiumzirconium oxidehemorrhagenanoparticlespolyphosphatessilicatestrauma

Identifiers

PMID25651530
PMCPMC4782980
OpenAlexW2133510622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.